Here, we demonstrate that empagliflozin exerts a protective role on β-cell mass after T1D onset, and that a 21-day treatment with GABA also improved β-cell mass in diabetic mice through α-cell proliferation and alleviation of iNos expression within islet cells. This evidence concerns the gene NOS2 and type 1 diabetes mellitus.